WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia

Dec.09.2022
WNBA Star Sentenced to 9 Years for Marijuana Possession in Russia
WNBA star Brittney Griner sentenced to nine years in Russian prison for possession of marijuana in her luggage.

According to Russian authorities, WNBA star Brittney Griner was found with a marijuana electronic pod in her carry-on luggage at a Moscow airport in February of this year. As a result, she has been sentenced to nine years in a Russian prison.


The two-time Olympic basketball champion and member of the US national team was arrested after being found in possession of a container of cannabis derivative oil.


Before announcing the verdict, Griner told the court that she inadvertently brought an electronic cigarette pod containing cannabis oil with her when she flew to Moscow to play basketball in Yekaterinburg in February.


The legality of possessing marijuana products varies by state and jurisdiction, which may impact the experiences of individuals traveling with such products.


In the United States, marijuana remains illegal under federal law.


Although cannabis is legal for adults in some states in the United States, it is still illegal according to federal law. It is not recommended to transport it across borders.


THC is the primary psychoactive substance in marijuana, while CBD is a non-psychoactive component of cannabis that is typically sold in other products such as lotions and supplements.


Certain cannabis-infused products, including CBD oil, are considered illegal at the federal level if they contain more than 0.3% delta-9-tetrahydrocannabinol (THC) by dry weight.


It is currently unclear whether the ammunition canister carried by Griner, as mentioned by Russian officials, contains either one or both of CBD or THC.


In January 2021, the organization reported that the US Food and Drug Administration has only approved one cannabis-derived product, Epidiolex, which contains purified CBD, as well as three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). These can only be obtained with a prescription from a licensed healthcare provider.


TSA Does Not Search for Drugs


Officials from the Transport Safety Management Bureau are required to report suspected illegal activities to local, state, or federal authorities, but they will not conduct searches for illegal drugs during screenings.


According to the website, TSA security personnel do not search for marijuana or other illegal drugs, but if any illegal substance is found during the security screening process, the TSA will report it to law enforcement officials.


The TSA has stated that their dogs cannot detect marijuana. However, in an Instagram post, they reiterated that in the screening process, if a substance or product infused with marijuana is found, even for medical use, law enforcement will be notified.


Carrying marijuana products while traveling abroad.


There are no specific guidelines for traveling internationally with cannabis products, but if a certain product is illegal in a particular country or region, carrying it while traveling could have consequences.


For instance, while marijuana is legal for adults in Canada, the government's tourism website states that transporting these products across the Canadian border, regardless of the amount of medical authorization, is illegal.


According to the website, this applies even if the person is traveling to and from a place where marijuana is decriminalized. The consequences of traveling with cannabis products may include being denied entry into a particular country or region.


According to the Canadian government website, "if you have used cannabis or any substance prohibited by local law in the past, you may be denied entry to your destination country." "You may also be refused entry to other countries in the future.


In recent years, Russia has arrested two women for similar reasons.


In Russia, cannabis for recreational or medicinal purposes is illegal.


In April 2019, an Israeli-American woman was arrested at Moscow airport while traveling from India to Israel and found with 9 grams of cannabis in her luggage, according to BBC News.


A 26-year-old woman, Naama Issachar, was sentenced to more than 7 years in prison for drug trafficking. According to the British Broadcasting Corporation, Russian President Vladimir Putin pardoned her in January 2020 before the visit of then-Israeli Prime Minister Benjamin Netanyahu to Moscow.


According to a report by The Moscow Times in September 2019, a film student from New York was charged with possession of drugs in St. Petersburg for allegedly bringing medical marijuana into the country.


2FIRSTS will continue to track and report on this topic, with updates available on the "2FIRSTS APP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Philip Morris International (PMI) has introduced the airport-exclusive limited-edition IQOS ILUMA i PRIME Skylens, the company’s first device created specifically for airport travel retail. Inspired by the world of flight and finished in metallic blue, Skylens debuted at Narita International Airport in Japan before expanding into selected airport duty-free and travel-retail channels across 13 countries in Europe, Asia, the Middle East and Africa. The product retains the existing IQOS ILUMA i PRIME platform, with differentiation centered on airport exclusivity, design and travel-retail execution rather than a new heating architecture.
PMI
Aug.19
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23